In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...

Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

MIBC requires a multimodal treatment approach, with radical cystectomy as the gold standard and bladder-sparing options for select patients. Adjuvant immunotherapies, such as nivolumab and ...

Direct-to-consumer devices promising pain relief are flooding the market. Is there enough evidence to recommend these devices to patients with chronic pain?

Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeksGood tolerability with no systemic side effectsFirst ...

Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...